|
| 36710205 | Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. | Eur Urol | 2024 |
| 38071746 | A digital male pelvis phantom series showing anatomical variations over the course of fractionated radiotherapy treatment. | Med Phys | 2024 |
| 37788716 | Age 70 +/- 5 Years and Cancer-Specific Outcomes After Treatment of Localized Prostate Cancer: A Systematic Review. | Int J Radiat Oncol Biol Phys | 2024 |
| 36269935 | Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials. | J Clin Oncol | 2023 |
| 37856213 | Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2023 |
| 37707545 | The National Cancer Institute's Cancer Disparities Research Partnership Program: a unique funding model 20 years later. | J Natl Cancer Inst | 2023 |
| 37428995 | Racism <i>Might</i> Cause Prostate Cancer and <i>Definitely</i> Causes Excess Unemployment, Lost Wages, and Excess Cancer Deaths. | J Clin Oncol | 2023 |
| 36592721 | Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2023 |
| 36882350 | AUA/ASTRO 2022 Guidelines: "Scrutinized". | Pract Radiat Oncol | 2023 |
| 36579470 | Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126. | Cancer | 2023 |
| 36868922 | Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. | Eur Urol Oncol | 2023 |
| 36596347 | Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. | Int J Radiat Oncol Biol Phys | 2023 |
| 36657093 | Re: Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. | JCO Oncol Pract | 2023 |
| 34618903 | Commentary: Race, COVID-19 and Nursing Homes. | J Infect Dis | 2022 |
| 36509074 | NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. | J Natl Compr Canc Netw | 2022 |
| 35934601 | Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN). | Eur Urol | 2022 |
| 36349917 | Editorial Comment. | J Urol | 2022 |
| 35282698 | Editorial Comment. | J Urol | 2022 |
| 35216858 | Race, Biology, Disparities, and Prostate Cancer. | Eur Urol | 2022 |
| 34844839 | Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings. | Eur J Cancer | 2022 |
| 34481017 | Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial. | Int J Radiat Oncol Biol Phys | 2022 |
| 34740768 | Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526). | Int J Radiat Oncol Biol Phys | 2022 |
| 32924093 | Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer. | Invest New Drugs | 2021 |
| 33545689 | NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. | J Natl Compr Canc Netw | 2021 |
| 33750437 | Radiotherapy of oligometastatic prostate cancer: a systematic review. | Radiat Oncol | 2021 |
| 34964855 | Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis. | JAMA Netw Open | 2021 |
| 34572433 | Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC). | Biomedicines | 2021 |
| 34077809 | Salvage High-Dose-Rate Brachytherapy for Recurrent Prostate Cancer After Definitive Radiation. | Pract Radiat Oncol | 2021 |
| 33275486 | Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis. | J Clin Oncol | 2021 |
| 33186617 | Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate. | Int J Radiat Oncol Biol Phys | 2021 |
| 33443566 | Radiation Delay Is Okay, but Where Is the Evidence? | JAMA Oncol | 2021 |
| 33387489 | Considering benefit and risk before routinely recommending SpaceOAR. | Lancet Oncol | 2021 |
| 32643031 | Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts. | World J Urol | 2021 |
| 32396488 | Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials. | J Clin Oncol | 2020 |
| 37317407 | Editorial Commentary. | Urol Pract | 2020 |
| 32001144 | Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. | Eur Urol | 2020 |
| 31839490 | Re: Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis. | Eur Urol | 2020 |
| 31980365 | Role of Para-aortic Radiotherapy in the Management of Prostate Cancer. | Clin Oncol (R Coll Radiol) | 2020 |
| 32890501 | Delaying Dilemmas: Coronavirus Complications Impacting the Management of Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2020 |
| 32909883 | Editorial Comment. | J Urol | 2020 |
| 32852528 | Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic Review. | JAMA Oncol | 2020 |
| 32922519 | Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancer. | Ther Adv Med Oncol | 2020 |
| 32444373 | The Roach Equation: Value of Old Clinical Tools in the Era of New Molecular Imaging. | J Nucl Med | 2020 |
| 32298811 | Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2020 |
| 30639140 | Surgery Versus Radiation for High-risk Prostate Cancer: The Fight Continues. But Is It Time To Call a Draw and Reach Consensus? | Eur Urol | 2019 |
| 31832217 | The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525. | Neurooncol Pract | 2019 |
| 31411984 | Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. | Eur Urol Oncol | 2019 |
| 31200844 | A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer. | Eur Urol Oncol | 2019 |
| 31120534 | Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. | JAMA Oncol | 2019 |
| 31085757 | Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2019 |